NZ775291A - Aerosolisable formulation - Google Patents
Aerosolisable formulationInfo
- Publication number
- NZ775291A NZ775291A NZ775291A NZ77529119A NZ775291A NZ 775291 A NZ775291 A NZ 775291A NZ 775291 A NZ775291 A NZ 775291A NZ 77529119 A NZ77529119 A NZ 77529119A NZ 775291 A NZ775291 A NZ 775291A
- Authority
- NZ
- New Zealand
- Prior art keywords
- aerosolised formulation
- aerosolised
- acid
- present
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/243—Nicotine
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
- A24B15/283—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by encapsulation of the chemical substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/10—Devices using liquid inhalable precursors
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Manufacture Of Tobacco Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
There is provided an aerosolised formulation comprising a vapour phase and a liquid water droplet phase, wherein the aerosolised formulation comprises (i) water in an amount of at least 50 wt.% based on the aerosolised formulation; (ii) one or more flavours; (iii) nicotine; (iv) 2-hydroxy-propyl derivatives of cyclodextrins and mixtures thereof; and (v) one or more acids; wherein at least 50 wt.% of the one or more flavours is present in the vapour phase, wherein an aerosol of the aerosolised formulation has a D10 of at least 0.5 µm.
Claims (26)
1. An aerosolised formulation comprising a vapour phase and a liquid water droplet phase, wherein the aerosolised formulation comprises 5 (i) water in an amount of at least 50 wt.% based on the aerosolised formulation; (ii) one or more flavours; (iii) nicotine; (iv) 2-hydroxy-propyl derivatives of cyclodextrins and mixtures thereof; and (v) one or more acids; 10 wherein at least 50 wt.% of the one or more flavours is present in the vapour phase, wherein an aerosol of the aerosolised formulation has a D10 of at least 0.5 µm.
2. An aerosolised formulation according to claim 1 wherein water is present in an amount of at least 75 wt.% based on the aerosolised formulation.
3. An aerosolised formulation according to claim 1 or 2 wherein water is present in an amount of at least 90 wt.% based on the aerosolised formulation.
4. An aerosolised formulation according to any one of claims 1 to 3 wherein the one or 20 more flavours are selected from the group consisting of (4-(para-)methoxyphenyl) butanone, vanillin, ?-undecalactone, menthone, 5-propenyl guaethol, menthol, para-mentha- 8-thiolone and mixtures thereof.
5. An aerosolised formulation according to claim 4 wherein the flavour is at least 25 menthol.
6. An aerosolised formulation according to any one of claims 1 to 5 wherein the one or more flavours are present in a total amount of no greater than 2wt.% based on the aerosolised formulation.
7. An aerosolised formulation according to any one of claims 1 to 6 wherein the one or more flavours are present in a total amount of from 0.01 to 1wt.% based on the aerosolised formulation. 35
8. An aerosolised formulation according to any one of claims 1 to 7 wherein at least 70 wt.% of the at least one flavour is present in the vapour phase.
9. An aerosolised formulation according to any one of claims 1 to 8 wherein at least 90 wt.% of the at least one flavour is present in the vapour phase.
10. An aerosolised formulation according to any one of claims 1 to 9 wherein at least 50 5 wt.% of the nicotine is present in the liquid water droplet phase.
11. An aerosolised formulation according to any one of claims 1 to 10 wherein at least 70 wt.% of the nicotine is present in the liquid water droplet phase 10
12. An aerosolised formulation according to any one of claims 1 to 11 wherein encapsulating material is present in a total amount of at least 1 wt.% based on the aerosolised formulation.
13. An aerosolised formulation according to any one of claims 1 to 12 wherein 15 encapsulating material is present in a total amount of no greater than 12 wt.% based on the aerosolised formulation.
14. An aerosolised formulation according to any one of claims 1 to 13 wherein the nicotine is present in an amount of no greater than 1wt.% based on the aerosolised 20 formulation.
15. An aerosolised formulation according to any one of claims 1 to 14 wherein the nicotine is present in an amount of from 0.01 to 0.6wt.% based on the aerosolised formulation.
16. An aerosolised formulation according to claim 1 wherein the acid is selected from the group consisting of acetic acid, lactic acid, formic acid, citric acid, benzoic acid, pyruvic acid, levulinic acid, succinic acid, tartaric acid, sorbic acid, propionic acid, phenylacetic acid, and mixtures thereof.
17. An aerosolised formulation according to claim 16 wherein the acid is selected from the group consisting of citric acid, benzoic acid, levulinic acid, sorbic acid, lactic acid, and mixtures thereof. 35
18. An aerosolised formulation according to any one of claims 16 or 17 wherein the acid is at least citric acid.
19. An aerosolised formulation according to any one of claims 1 to 18 wherein the aerosolisable formulation contains no flavours that can be encapsulated by the one or more cyclodextrins. 5
20. A process for forming an aerosol, the process comprising aerosolising an aerosolisable formulation comprising (i) water in an amount of at least 50 wt.% based on the aerosolised formulation; (ii) one or more flavours; (iii) nicotine; 10 (iv) 2-hydroxy-propyl derivatives of cyclodextrins and mixtures thereof; and (v) one or more acids; to provide an aerosol comprising a vapour phase and a liquid water droplet phase, wherein at least 50 wt.% of the one or more flavours is present in the vapour phase, wherein the aerosol has a D10 of at least 0.5 µm.
21. A process according to claim 20 wherein the aerosolisable formulation is a formulation as defined in any one of claims 2 to 19.
22. A process according to claim 20 or 21 wherein the aerosol is formed by a process 20 performed at a temperature below 50°C.
23. A process according to claim 20, 21 or 22 wherein the aerosol is formed by applying ultrasonic energy to the aerosolised formulation. 25
24. An electronic aerosol provision system comprising: (a) an aerosoliser for aerosolising formulation for inhalation by a user of the electronic aerosol provision system; (b) a power supply comprising a cell or battery for supplying power to the aerosoliser (c) aerosolisable formulation comprising 30 (i) water in an amount of at least 50 wt.% based on the aerosolised formulation; (ii) one or more flavours; (iii) nicotine; (iv) 2-hydroxy-propyl derivatives of cyclodextrins and mixtures thereof; and (v) one or more acids; 35 wherein the aerosoliser provides an aerosol comprising a vapour phase and a liquid water droplet phase, wherein at least 50 wt.% of the one or more flavours is present in the vapour phase, wherein the aerosol has a D10 of at least 0.5 µm.
25. An electronic aerosol provision system according to claim 24 wherein the aerosolised formulation is an aerosolised formulation as defined in any one of claims 2 to 19. 5
26. A process for improving delivery of flavour to an aerosolised formulation, the process comprising the steps of (a) providing an aerosolisable composition comprising (i) water in an amount of at least 50 wt.% based on the aerosolised formulation; (ii) one or more flavours; 10 (iii) nicotine; (iv) 2-hydroxy-propyl derivatives of cyclodextrin and mixtures thereof; and (v) one or more acids; (b) aerosolising the aerosolisable composition to provide an aerosol comprising a vapour phase and a liquid water droplet phase, wherein at least 50 wt.% of the one or more flavours 15 is present in the vapour phase, wherein the aerosol has a D10 of at least 0.5 µm. -1 -0.5 0 0.5 1.0 1.5 log [conc]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1817862.4A GB201817862D0 (en) | 2018-11-01 | 2018-11-01 | Aerosolisable formulation |
| PCT/GB2019/053089 WO2020089635A1 (en) | 2018-11-01 | 2019-10-31 | Aerosolisable formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NZ775291A true NZ775291A (en) | 2024-09-27 |
| NZ775291B2 NZ775291B2 (en) | 2025-01-07 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024024046A (en) | 2024-02-21 |
| BR112021008561A2 (en) | 2021-08-03 |
| IL282461A (en) | 2021-06-30 |
| CN113038842B (en) | 2023-11-03 |
| US20230165299A1 (en) | 2023-06-01 |
| EP3873243A1 (en) | 2021-09-08 |
| JP2022506102A (en) | 2022-01-17 |
| KR102782830B1 (en) | 2025-03-14 |
| MY205404A (en) | 2024-10-20 |
| US12193471B2 (en) | 2025-01-14 |
| IL282461B1 (en) | 2024-07-01 |
| IL282461B2 (en) | 2024-11-01 |
| EP3873243B1 (en) | 2025-07-23 |
| GB201817862D0 (en) | 2018-12-19 |
| WO2020089635A1 (en) | 2020-05-07 |
| AU2019370809B2 (en) | 2022-12-01 |
| CA3118047A1 (en) | 2020-05-07 |
| AU2019370809A1 (en) | 2021-05-20 |
| UA127837C2 (en) | 2024-01-17 |
| PL3873243T3 (en) | 2025-11-12 |
| KR20210070333A (en) | 2021-06-14 |
| MX2021005117A (en) | 2021-06-15 |
| CN113038842A (en) | 2021-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL305868A (en) | Vaporisable formulation | |
| NZ775291A (en) | Aerosolisable formulation | |
| NZ775291B2 (en) | Aerosolisable formulation | |
| IL274138B2 (en) | Flavoured vaporisable formulation | |
| CN103865276A (en) | Active antibacterial edible package with controlled release function and preparation method thereof | |
| NZ775136A (en) | Aerosolisable formulation | |
| NZ775136B2 (en) | Aerosolisable formulation | |
| NZ775331A (en) | Aerosolisable formulation | |
| NZ775294B2 (en) | Aerosolised formulation | |
| NZ775331B2 (en) | Aerosolisable formulation | |
| NZ775294A (en) | Aerosolised formulation | |
| NZ775410B2 (en) | Aerosolisable formulation | |
| NZ775410A (en) | Aerosolisable formulation | |
| NZ775338B2 (en) | Aerosolised formulation | |
| NZ775338A (en) | Aerosolised formulation | |
| NZ775353A (en) | Aerosolisable formulation | |
| NZ775417A (en) | Aerosolisable formulation | |
| CN102524243A (en) | Preservative for fresh flower | |
| NZ775417B2 (en) | Aerosolisable formulation | |
| NZ775292A (en) | Aerosolisable formulation | |
| RU2021112009A (en) | AEROSOL-CAPABLE COMPOSITION | |
| NZ775292B2 (en) | Aerosolisable formulation | |
| CN118489745A (en) | A kind of emulsion coating preservative with fast curing performance and its preparation method and application | |
| RU2021112078A (en) | COMPOSITION CAPABLE OF FORMING AEROSOL, METHOD FOR ITS FORMATION AND ELECTRONIC AEROSOL PROVISION SYSTEM | |
| CN101536635A (en) | Method for reducing nicotine content |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 OCT 2026 BY MS. MANDY LAUBACH Effective date: 20251021 |